Aethlon Medical to Present at Bird Flu Summit
10 February 2006 - 12:00AM
Business Wire
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing
therapeutic devices for infectious disease, announced today that
its Chairman and CEO, James A. Joyce, will present at The Bird Flu
Summit, to be held in Washington, DC on February 27-28, 2006. Mr.
Joyce's presentation is scheduled to begin at 3:30pm EST on
February 27th, and is entitled, "The Aethlon Hemopurifier(TM) as a
Treatment for Drug Resistant Avian Flu." Additional conference
details can be accessed at www.bfsummit.com. About Aethlon Medical
Aethlon Medical is developing the first medical device to treat
infectious disease. The device, known as the Hemopurifier(TM), is a
broad-spectrum treatment countermeasure against drug and vaccine
resistant bioweapons, naturally evolving pandemic threats such as
H5N1 Avian Flu, and chronic infectious disease targets including
Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV). More
information on Aethlon Medical and the Hemopurifier(TM) technology
can be found at www.aethlonmedical.com. Certain of the statements
herein may be forward-looking and involve risks and uncertainties.
Such forward-looking statements involve assumptions, known and
unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of Aethlon Medical, Inc
to be materially different from any future results, performance, or
achievements expressed or implied by the forward-looking
statements. Such potential risks and uncertainties include, without
limitation, the Company's ability to raise capital when needed, the
Company's ability to complete the development of its planned
products, the ability of the Company to obtain FDA and other
regulatory approvals permitting the sale of its products, the
Company's ability to manufacture its products and provide its
services, the impact of government regulations, patent protection
on the Company's proprietary technology, product liability
exposure, uncertainty of market acceptance, competition,
technological change, and other risk factors. In such instances,
actual results could differ materially as a result of a variety of
factors, including the risks associated with the effect of changing
economic conditions and other risk factors detailed in the
Company's Securities and Exchange Commission filings.
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From Apr 2024 to May 2024
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Atlas Copco Corporation (PK) (OTCMarkets): 0 recent articles
More Aethlon Medical, Inc. News Articles